Twist Bioscience Corporation (TWST) Tops Q4 EPS by 36c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2022 Financial Results
November 18, 2022 7:30 AM EST-- Record revenue of $203.6 million in Fiscal 2022; Increase of 54% over $132.3 million in Fiscal 2021
-- Orders increased to $226 million in Fiscal 2022; Increase of 42% over $160 million in Fiscal 2021 --
Expect revenue in the range of $261 million to $269 million for full year Fiscal 2023 --
Expect revenue of $350 million for full year Fiscal 2024 --
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--
... More


